FIELD: medicine.
SUBSTANCE: method involves introduction in a period of premonitory signs, not later than after the first 6 hours of the symptoms of genital and urogenital herpetic infection, a combination of two antiviral preparations: allokin-alpha 1 mg, once a day, every second day, a therapeutic course of 3 subcutaneous injections and oral single dose of famciclovir 1500 mg, and also external therapy of infagel 2 times a day for 5 days.
EFFECT: use of the invention enables reducing formation of vesicles and urogenital mucosal erosions, decreasing length of recurrences and a prolonged intercurrent period.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIAGNOSTIC TECHNIQUE FOR REMITTED GENITAL AND UROGENITAL HERPETIC INFECTION | 2010 |
|
RU2429781C1 |
| METHOD OF TREATMENT OF PATIENTS WITH HERPES VIRUS INFECTION USING IN VITRO ACTIVATED AUTOLOGICAL LYMPHOCYTES | 2022 |
|
RU2799141C2 |
| METHOD TO TREAT FEMALE RECURRENT GENITAL HERPES | 1999 |
|
RU2179849C2 |
| METHOD OF TREATING INFECTIONS INDUCED BY HERPES SIMPLEX VIRUSES TYPE I AND II, CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS | 2008 |
|
RU2391981C2 |
| METHOD FOR PREVENTION AND TREATMENT OF CHRONIC, FREQUENTLY RECURRENT HERPES VIRUS INFECTION | 2008 |
|
RU2373951C1 |
| METHOD FOR TREATMENT OF PATIENTS WITH RELAPSING GENITAL HERPES IN FORMATION OF ANXIOUS-DEPRESSIVE DISORDERS | 2004 |
|
RU2270012C2 |
| METHOD OF TREATMENT FOR GENITAL HERPES | 2007 |
|
RU2339377C1 |
| METHOD FOR INDIVIDUAL APPROACH TO TREATING RECURRENT GENITAL HERPES IN WOMEN | 2015 |
|
RU2585107C1 |
| METHOD OF TREATING SKIN AND MUCOSAL DISEASES CAUSED BY HERPES SIMPLEX VIRUSES TYPE 1 AND TYPE 2 | 2013 |
|
RU2530587C1 |
| METHOD OF INCREASING CLINICAL IMMUNE EFFICIENCY OF GENITAL HERPES THERAPY USING INTRAVASCULAR BLOOD LASER EXPOSURE | 2015 |
|
RU2602304C1 |
